The Long-term Course of Moderate Tricuspid Regurgitation

IRCCS San Raffaele250 enrolled

Overview

To evaluate the long-term clinical outcome of a cohort of patients suffering from moderate tricuspid regurgitation (TR), regardless of its etiology.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Tricuspid Regurgitation Heart Failure Echocardiography

Interventions

Echocardiographic evaluationOTHER

Echocardiographic follow-up

Eligibility

Sex: ALLMin age: 18 YearsMax age: 95 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients with an echocardiographic diagnosis of moderate TR 2. Patients with echocardiographic and clinical follow-up information available at least 6-months after moderateTR diagnosis. Exclusion Criteria: 1. Absence of an appropriate clinical and echocardiographic follow-up 2. A history of previous TV intervention (either surgical or percutaneous) 3. The presence of concomitant TV stenosis 4. Congenital heart disease 5. Left ventricular assist devices

Locations (1)

Irccs San Raffaele

Milan, Italy

Outcomes

Primary Outcomes

All-cause death

Time from diagnosis to all-cause death

Time frame: through study completion, an average of 2 years

Secondary Outcomes

Cardiovascular (CV) mortality

The occurrence of cardiovascular (CV) mortality (defined as death due to advanced heart failure, coronary ischemic heart disease, sudden cardiac death or due to stroke

Time frame: through study completion, an average of 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.